Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT03836521
- Status
- Recruiting
Conditions
- Bicuspid Aortic Valve
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 129 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcatheter aortic valve replacement — DEVICE
Study Details
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Key Dates
- Start date
- Aug 15, 2016
- Status verified
- Feb 2019
- Primary completion
- Aug 15, 2028
- Completion
- Aug 15, 2028
Study Design
- Enrollment
- 2,000 participants (estimated)
Primary Outcome Measure
Death [ Time Frame: 1 month ]
Central Contacts
- Sung-Han Yoon, M.D.3104237426
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot TrialRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Bicuspid Aortic Valve (BAV) RegistryRecruiting · University of Michigan · Ann Arbor, Michigan